1. Home
  2. COTY vs NKTR Comparison

COTY vs NKTR Comparison

Compare COTY & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coty Inc.

COTY

Coty Inc.

HOLD

Current Price

$2.15

Market Cap

1.9B

ML Signal

HOLD

Logo Nektar Therapeutics

NKTR

Nektar Therapeutics

HOLD

Current Price

$77.40

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COTY
NKTR
Founded
1904
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.1B
IPO Year
2012
1996

Fundamental Metrics

Financial Performance
Metric
COTY
NKTR
Price
$2.15
$77.40
Analyst Decision
Hold
Strong Buy
Analyst Count
17
7
Target Price
$4.34
$130.00
AVG Volume (30 Days)
7.3M
760.4K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,892,900,000.00
$307,711,000.00
Revenue This Year
$0.19
N/A
Revenue Next Year
$1.30
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
86.00
52 Week Low
$1.95
$0.57
52 Week High
$5.34
$78.81

Technical Indicators

Market Signals
Indicator
COTY
NKTR
Relative Strength Index (RSI) 44.11 59.78
Support Level $1.95 $64.30
Resistance Level $3.43 N/A
Average True Range (ATR) 0.09 4.64
MACD 0.03 0.03
Stochastic Oscillator 70.09 89.76

Price Performance

Historical Comparison
COTY
NKTR

About COTY Coty Inc.

Coty is a global beauty maker that generates 65% of sales from prestige beauty products (primarily fragrances) and 35% from mass makeup, skin care, and fragrance. For the fragrance business, Coty licenses luxury and high-end brands including Gucci, Burberry, Hugo Boss, Davidoff, and Calvin Klein. In contrast, its consumer cosmetics business focuses on acquired mass brands such as CoverGirl, Max Factor, Rimmel, Sally Hansen, and Bourjois. It also collaborates with social media celebrity Kylie Jenner to manage makeup products bearing her name. By region, Coty generates close to 48% of sales from Europe, 40% from the Americas, and 12% from Asia-Pacific. German investment firm JAB is a controlling shareholder, with a 54% stake.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.

Share on Social Networks: